These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20547900)

  • 1. ACP Journal Club. Rosuvastatin prevented ischemic stroke in healthy older adults with elevated C-reactive protein.
    Cruz-Flores S
    Ann Intern Med; 2010 Jun; 152(12):JC6-6. PubMed ID: 20547900
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP Journal Club. Rosuvastatin reduced venous thromboembolism in healthy older adults with elevated C-reactive protein levels.
    Levi M
    Ann Intern Med; 2009 Sep; 151(6):JC3-10. PubMed ID: 19755356
    [No Abstract]   [Full Text] [Related]  

  • 3. ACP Journal Club. Rosuvastatin prevented major cardiovascular events in persons with elevated C-reactive protein.
    Campbell-Scherer DL; Montori VM
    Ann Intern Med; 2009 Jan; 150(2):JC1-4. PubMed ID: 19172709
    [No Abstract]   [Full Text] [Related]  

  • 4. Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER).
    Everett BM; Glynn RJ; MacFadyen JG; Ridker PM
    Circulation; 2010 Jan; 121(1):143-50. PubMed ID: 20026779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACP Journal Club. Oral anticoagulant therapy safely prevented stroke in older patients with atrial fibrillation.
    Dunn A
    Ann Intern Med; 2009 Jul; 151(2):JC1-4. PubMed ID: 19620148
    [No Abstract]   [Full Text] [Related]  

  • 6. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).
    Ridker PM; MacFadyen JG; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):616-23. PubMed ID: 20031900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACP Journal Club. Various risk stratification schemes predict ischemic stroke and bleeding in atrial fibrillation.
    Gage BF; Andrade A
    Ann Intern Med; 2012 Oct; 157(8):JC4-13. PubMed ID: 23070515
    [No Abstract]   [Full Text] [Related]  

  • 8. ACP Journal Club. The PLAN score predicted death and severe disability in patients with acute ischemic stroke.
    Rowland K
    Ann Intern Med; 2013 Feb; 158(4):JC13. PubMed ID: 23420250
    [No Abstract]   [Full Text] [Related]  

  • 9. ACP Journal Club. rt-PA within 6 hours of acute ischemic stroke did not improve clinical outcomes at 6 months.
    van Adel B; Oczkowski W
    Ann Intern Med; 2012 Nov; 157(10):JC5-7. PubMed ID: 23165683
    [No Abstract]   [Full Text] [Related]  

  • 10. ACP Journal Club. Citicoline did not improve recovery at 90 days after moderate-to-severe acute ischemic stroke.
    Alberts MJ
    Ann Intern Med; 2012 Sep; 157(6):JC3-13. PubMed ID: 22986405
    [No Abstract]   [Full Text] [Related]  

  • 11. ACP Journal Club. Review: Insulin to maintain normoglycemia within 24 hours of ischemic stroke does not reduce death or dependency.
    Wasielewski PG; Uchino K
    Ann Intern Med; 2011 Dec; 155(12):JC6-5. PubMed ID: 22184706
    [No Abstract]   [Full Text] [Related]  

  • 12. ACP Journal Club. Prasugrel prevented ischemic events compared with clopidogrel in patients having PCI for STEMI.
    Hillegass WB; Brott BC
    Ann Intern Med; 2009 Jun; 150(12):JC6-10. PubMed ID: 19528555
    [No Abstract]   [Full Text] [Related]  

  • 13. ACP Journal Club. In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone.
    Wang AT; Smith SA
    Ann Intern Med; 2010 Dec; 153(12):JC6-11. PubMed ID: 21173400
    [No Abstract]   [Full Text] [Related]  

  • 14. ACP Journal Club. Compared with warfarin, high-dose dabigatran might be cost-effective for preventing stroke in older patients with nonvalvular AF.
    Masoodi NA
    Ann Intern Med; 2011 Jun; 154(12):JC6-12. PubMed ID: 21690590
    [No Abstract]   [Full Text] [Related]  

  • 15. ACP Journal Club. Review: Calcium supplements increase risk for myocardial infarction but not mortality or stroke in adults.
    Ensrud KE
    Ann Intern Med; 2010 Nov; 153(10):JC5-7. PubMed ID: 21079214
    [No Abstract]   [Full Text] [Related]  

  • 16. ACP Journal Club. Candesartan did not improve clinical or functional outcomes in patients with acute stroke and elevated BP.
    Frieden R
    Ann Intern Med; 2011 Jun; 154(12):JC6-5. PubMed ID: 21690583
    [No Abstract]   [Full Text] [Related]  

  • 17. ACP Journal Club. Apixaban reduced stroke and systemic embolism compared with aspirin in adults with AF for whom VKA therapy was unsuitable.
    Dunn A
    Ann Intern Med; 2011 Apr; 154(8):JC4-3. PubMed ID: 21502641
    [No Abstract]   [Full Text] [Related]  

  • 18. ACP Journal Club. Flexible sigmoidoscopy screening reduced colorectal cancer incidence and mortality in older adults.
    Kahi CJ; Imperiale TF
    Ann Intern Med; 2012 Sep; 157(6):JC3-3. PubMed ID: 22986395
    [No Abstract]   [Full Text] [Related]  

  • 19. ACP Journal Club. The Cardiovascular Health Awareness Program reduced CV hospitalizations but not mortality in older adults.
    Elley CR; Kerse N
    Ann Intern Med; 2011 Jun; 154(12):JC6-3. PubMed ID: 21690581
    [No Abstract]   [Full Text] [Related]  

  • 20. ACP Journal Club. Review: Vitamin D supplementation improves some balance measures but not muscle strength in older adults.
    Aung K
    Ann Intern Med; 2012 May; 156(10):JC5-8. PubMed ID: 22586026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.